Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAIN-2: Intense vs Tailored Dose-Dense Chemotherapy in Early Breast Cancer
NCT01690702Phase 3Completed
- Sponsor
- GBG Forschungs
- Start
- Sep 2012
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel in breast cancer, sponsored by GBG Forschungs. Started Sep 2012; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01690702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01690702.